Peptide record

TPDB05404

Antibacterial Anticancer Antifungal Antiparasitic Cell-penetrating Peptides Hemolysis Toxicity standard
23 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB05404
Antibacterial Anticancer Antifungal Antiparasitic Cell-penetrating Peptides Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides Delivery and barrier-penetrating peptides
AntiBP3 dbAMP DRAMP Peptipedia Antifungipept i2APP HemoPI Hemolytic2 PD_Hemolysis ToxinPred 3.0
standard
No
A 23-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
FHPSLWVLIPQYIQLIRKILKSG
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C134H213N33O29
ANDCEMT
IL
2750.37
10.72
4
0
12
+3
-0.04
0.448
148.26
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
6990
2.54
5
Residue Composition
number
0
A
1
R
0
N
0
D
0
C
0
E
2
Q
1
G
1
H
4
I
4
L
2
K
0
M
1
F
2
P
2
S
0
T
1
W
1
Y
1
V
Amino Acid Distribution
A: 0 R: 1 N: 0 D: 0 C: 0 E: 0 Q: 2 G: 1 H: 1 I: 4 L: 4 K: 2 M: 0 F: 1 P: 2 S: 2 T: 0 W: 1 Y: 1 V: 1
Chemical Descriptors
23 reviewed residue count
C134H213N33O29 sequence-only estimate (linear, free termini)
2750.37 sequence-only estimate (linear, free termini)
10.72 sequence-only estimate (linear, free termini)
+3 sequence-only estimate (linear, free termini)
-0.04 sequence-only estimate (linear, free termini)
0.448 sequence-only estimate (linear, free termini)
Evidence Records 10 records
Evidence 1 Activity

Activity

% Hemolysis
Hemolysis
95 %
[Ref.17927208]95% hemolytic activity at 25 µM against human red blood cells

Target

human red blood cells

Source & Reference

Hemolytik PD_Hemolysis
DRAMP4
Biochemistry. 2007 Nov 6 46(44):12586-12593.

Other

Source Activity Label Source Definition
Hemolysis
Hemolytik experimentally validated hemolytic peptide annotation.
Evidence 2 Activity

Activity

40% Hemolysis
Toxicity
1 µM
Hemolytic Cytotoxic
40% Hemolysis | 1 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Conolysin-Mt: a conus peptide that disrupts cellular membranes | Biochemistry | 2007
Evidence 3 Activity

Activity

90% Hemolysis
Toxicity
10 µM
Hemolytic Cytotoxic
90% Hemolysis | 10 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Conolysin-Mt: a conus peptide that disrupts cellular membranes | Biochemistry | 2007
Evidence 4 Activity

Activity

IC50
Toxicity
2.85±0.29 µM
Cytotoxic
IC50 | 2.85±0.29 | µM | target cell: Human pancreas epithelial cells HPNE

Target

Human pancreas epithelial cells HPNE

Source & Reference

NA
DBAASP
Discovery of anticancer peptides from natural and generated sequences using deep learning. | Int J Biol Macromol | 2025
Evidence 5 Activity

Activity

IC50
Toxicity
1.32±0.06 µM
Cytotoxic
IC50 | 1.32±0.06 | µM | target cell: Human umbilical vein endothelial cells HUVEC

Target

Human umbilical vein endothelial cells HUVEC

Source & Reference

NA
DBAASP
Discovery of anticancer peptides from natural and generated sequences using deep learning. | Int J Biol Macromol | 2025
Evidence 6 Activity

Activity

IC50
Toxicity
4.70±0.20 µM
Cytotoxic
IC50 | 4.70±0.20 | µM | target cell: Human keratinocytes HaCat

Target

Human keratinocytes HaCat

Source & Reference

NA
DBAASP
Discovery of anticancer peptides from natural and generated sequences using deep learning. | Int J Biol Macromol | 2025
Evidence 7 Activity

Activity

IC50
Toxicity
7.29±0.69 µM
Cytotoxic
IC50 | 7.29±0.69 | µM | target cell: Human embryonic kidney HEK293T cells

Target

Human embryonic kidney HEK293T cells

Source & Reference

NA
DBAASP
Discovery of anticancer peptides from natural and generated sequences using deep learning. | Int J Biol Macromol | 2025
Evidence 8 Activity

Activity

50% Hemolysis
Toxicity
25 µM
Hemolytic Cytotoxic
50% Hemolysis | 25 | µM | target cell: Mouse erythrocytes

Target

Mouse erythrocytes

Source & Reference

NA
DBAASP
Discovery of anticancer peptides from natural and generated sequences using deep learning. | Int J Biol Macromol | 2025
Evidence 9 Activity

Activity

Toxicity
Hemolytic
Hemolytic_activity: [Ref.17927208]95% hemolytic activity at 25 µM against human red blood cells

Target

erythrocytes

Source & Reference

NA
DRAMP
Biochemistry. 2007 Nov 6 46(44):12586-12593.
Evidence 10 Hemolysis

Activity

95 %
% Hemolysis
[Ref.17927208]95% hemolytic activity at 25 µM against human red blood cells
Hemolysis

Target

human red blood cells

Source & Reference

HemoPI PD_Hemolysis
Biochemistry. 2007 Nov 6 46(44):12586-12593.
DRAMP4
PD_Hemolysis